Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 3, 2010, Pages e95-e101

  Zuppa, Antonio Alberto ^a   Alighieri, Giovanni ^a   Calabrese, Valentina ^a   Visintini, Federica ^a   Cota, Francesco ^a   Carducci, Chiara ^a   Antichi, Eleonora ^a   Noia, Giuseppe Antonio ^a   Fortunato, Giuseppe ^a   Romagnoli, Costantino ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Erythropoietin; Fetal anemia; Intrauterine transfusion; Rh hemolytic disease; Rhesus alloimmunization

Indexed keywords

ALPHA TOCOPHEROL; FOLINATE CALCIUM; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MALE; NEUTROPHIL COUNT; NEWBORN; PRIORITY JOURNAL; RETICULOCYTE COUNT; RHESUS ISOIMMUNIZATION; THROMBOCYTE COUNT;

ANEMIA; BLOOD TRANSFUSION; BLOOD TRANSFUSION, INTRAUTERINE; COHORT STUDIES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GESTATIONAL AGE; HEMATOCRIT; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; RH ISOIMMUNIZATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77951094227     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181cf444c     Document Type: Article

References (28)

1. Fairchild KD, Mckenzie SE. Hemolytic disease of the newborn. Curr Pediatr Ther. 1999;16: 313-318.
2. Contreras M. The prevention of Rh haemolytic disease of the fetus and newborn - general background. Br J Obstet Gynaecol. 1998;105(suppl 18): 7-10.
3. Urbaniak SJ. The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol. 1998;105(suppl 18): 11-18.
4. Levine P, Katzin EM, Burnham L. Isoimmunization in pregnancy: it’s possible bearing on the etiology of erythroblastosis fetalis. JAMA. 1941;116: 825-827.
5. Zipursky A, Bowman JM. Isoimmune hemolytic diseases. In: Nathan DG, Oski FA, eds. Hematology of Infancy and Childhood. Philadelphia: Saunders; 1992: 44-73.
6. Ohls RK, Wirkus PE, Christensen RD, et al. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics. 1992;90: 678-680.
7. Millard DD, Gidding SS, Socol ML, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr. 1990;117: 447-454.
8. Scaradavou A, Inglis S, Peterson P, et al. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr. 1993;123: 279-284.
9. Thorp JA, O’Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol. 1991;165: 79-81.
10. Ovaly F. Late anemia in Rh haemolytic disease. Arch Dis Child Fetal Neonatal Ed. 2003;88: 444.
11. Nicaise C, Gire C, Casha P, et al. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion. Fetal Diagn Ther. 2002;17: 22-24.
12. Dallacasa P, Ancora G, Miniero R, et al. Erythropoietin course in newborns with Rh hemolytic disease transfused and not transfused in utero. Pediatr Res. 1996;40: 357-360.
13. Zuppa AA, Maragliano G, Scapillati ME, et al. Recombinant erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-haemolytic disease. Fetal Diagn Ther. 1999;14: 270-274.
14. Bussel JB, Inglis SR, Chervenak FA. Erythropoietin treatment for anemia in Rh disease. Pediatr Res. 1992;31: 265.
15. Ovaly F, Samanci N, Dagoglu T. Management of late anemia in rhesus hemolytic disease: use of recombinant human erytropoietin (A Pilot Study). Pediatr Res. 1996;39: 831-834.
16. Wacker P, Ozsahin H, Stelling MJ, et al. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin. Pediatr Hematol Oncol. 2001;18: 279-282.
17. Bertino E, Murru P, Bagna R, et al. Standard antropometrici neontatali dell’Italia Nord-Occidentale. Riv Ital Pediatr. 1999;25: 899-906.
18. Nicolaides KH, Soothil PW, Rodeck CH, et al. Intravascular fetal blod transfusion by cordocentesis. Fetal Ther. 1986;1: 185-189.
19. Plecas DV, Chitkara U, Berkowitz GS, et al. Intrauterine intravascular transfusion for severe erythroblastosis fetalis. How much to transfuse? Obstet Gynecol. 1990;75: 965-969.
20. Koenig JM, Ashton DR, De Vore GR. Late hyporegenerative anemia in Rh hemolytic disease. J Pediatr. 1989;115: 315-318.
21. Al-Alaiyan S, Al Omran A. Late Hyporegenerative anemia in neonates with rhesus hemolytic disease. J Perinat Med. 1999;27: 112-115.
22. De Boer IP, Zeestraten EC, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol. 2008;198: 54.e1-54.e4.
23. Gottstein R, Cooke RWI. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal. 2003;88: 6-10.
24. Urbaniak SJ. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis. Br J Haematol. 1979;42: 315-325.
25. Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr. 1992;121: 93-97.
26. Alpay F, Sarici SU, Okutan V, et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr. 1999;88: 216-219.
27. Rubo J, Albrecht K, Lasch P, et al. Influence of high dosage immunoglobulin therapy on hyperbilirubinemia in rhesus hemolytic disease. A co-operative study. Monatsschr Kinderheilk. 1996;144: 516-519.
28. Kriplani A, Singh BM, Mandal K. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease. Gynecol Obstet Invest. 2007;63: 176-180.